Pharma Journalist - Page 694 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Intralytix sought FDA clearance to begin Phase I/IIa Clinical Trials for bacteriophages

Regentys collaborates with Cook Biotech to curate Unique Ulcerative Colitis Treatment

Astellas Pharma obtains Universal Cells

Servier and ImmunoQure partner to advance human Interferon-α autoantibody

Spineology finishes enrollment in IDE Trial for Mesh Fusion Transplant

FDA concedes Glooko’s Mobile Insulin Dosing System

Bristol-Myers Squibb and Nektar Therapeutics collaborate commercially for NKTR-214

OTTR partners Hemasoft to facilitate transfusion medicine

IRX Therapeutics commences Phase 2 Clinical Trial for CIN3 or VIN3 women

Neurocrine Biosciences files NDA for opicapone for Parkinson’s disease